 |
|
Volume 10, Number 4 |
|
| Air travel and the risk of thrombosis |
Sarah Bond MRPharmS MSc Clin Pharm Anticoagulant Specialist Pharmacist, Great Western Hospital, Swindon |
Evidence has been slow to emerge to conclusively prove that long haul travel and venous thromboembolism (VTE) are linked. There can be so many variations in each journey and each individual that generalising data is not easy. However, it is now probable that among potential risk factors for triggering thrombosis, sitting for prolonged periods does play an important role as this can cause venous stasis. |
|
| Haematology nursing at the BSH conference, Edinburgh 2006 |
Michelle Taylor RGN Anticoagulant and Haematology Specialist Nurse, Great Western Hospital, Swindon |
A commitment to providing more time for nursing issues at the British Society of Haematology (BSH) conferences has been steadily gaining momentum over the last few years. At the 46th annual BSH meeting in Edinburgh from 3–5 April 2006, a whole day was dedicated to nursing symposia for the first time, highlighting the continued innovations and research-based findings within haematology presented by specialist nurses. |
|
| PE and the benefits of LMWH |
Marion Delcroix MD PhD Pneumology Department, University Hospital Leuven, Belgium; Member of the Pulmonary Vascular Pathology Task Force of the Belgian Society of Pneumology |
The aim of the Belgian Society of Pneumology task force* was to issue guidelines for practitioners, answering simple and practical questions, and emphasising the particularities of pulmonary embolism (PE) compared to venous thromboembolism (VTE). |
|
| A case of DVT in a 13-year-old girl with osteochondroma |
Sarah Bond MRPharmS MSc Clin Pharm Anticoagulant Specialist Pharmacist, Great Western Hospital, Swindon |
A 13-year-old girl presented to hospital via her GP with a three-day history of left leg pain from mid-thigh to calf and a difficulty in weight bearing. She had pulled a muscle in dance class six weeks earlier, which had resulted in a painful leg, but this had resolved without treatment. |
|
| Self-management of oral anticoagulation: the SMART study |
David Fitzmaurice FRCGP MD Professor of Primary Care Research, The Medical School, University of Birmingham |
The expansion of clinical indications for oral anticoagulation therapy (primarily warfarin in the UK),1,2 particularly non-rheumatic atrial fibrillation,3,4 has raised concerns over how therapeutic monitoring should be undertaken.5,6 The significance of this issue for all healthcare systems with aging populations can be estimated from data showing that of patients with identified atrial fibrillation, only one-third are currently receiving anticoagulation.7 |
|
